Skip to main content
Caplight Logo









EntroGen, Inc.

EntroGen, Inc.

Private
Woodland Hills, CaliforniaHealthcare & Life Scienceshttps://entrogen.com/web4

Momentum

Top 25%

of companies Caplight tracks

Company Overview

EntroGen, Inc. operates in Healthcare & Life Sciences and is based in Woodland Hills, California. It was founded in 2007.

EntroGen, Inc. is a biotechnology company that develops and offers end-to-end solutions in molecular diagnostics for oncology and hematology by providing hardware, reagents, and software.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Precision Medicine, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

EntroGen, Inc. Comparables

Compare EntroGen, Inc. with similar companies based on industry and business-model similarity.

EntroGen, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Pillar Biosciences
84%
Amoy Diagnostics Co., Ltd.
79%
Luye Pharma Group
76%
Book a demo to see all comparables

For institutional investors. Book with your work email.

EntroGen, Inc. Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for EntroGen, Inc.. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 46% MoM.

  • Jul 27, 2026

    Monthly visitors increased 34% MoM, reaching 2.2K.

Book a demo to see all signals

For institutional investors. Book with your work email.

EntroGen, Inc. Filings

Explore SEC and related filing metadata, where available.

EntroGen, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about EntroGen, Inc.'s valuation, stock price, and market status.

Is EntroGen, Inc. a public or private company?

EntroGen, Inc. is a private company.

What is the current stock price of EntroGen, Inc.?

EntroGen, Inc. is a private company, so its shares have no public market price. Caplight tracks EntroGen, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is EntroGen, Inc. worth (valuation)?

Valuation information for EntroGen, Inc. is not publicly available.

Can I buy EntroGen, Inc. stock?

EntroGen, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was EntroGen, Inc.'s last funding round?

Funding round information for EntroGen, Inc. is not publicly available.

Who are the main investors in EntroGen, Inc.?

Investor information for EntroGen, Inc. is not publicly disclosed.

Will EntroGen, Inc. IPO soon?

No public IPO plans have been announced for EntroGen, Inc..

How can I track EntroGen, Inc. secondary market activity?

Caplight tracks bids, offers, and trades in EntroGen, Inc.'s shares on secondary markets.

Firmographic Details

HeadquartersWoodland Hills, California
Employee Range22
Year Founded2007
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?